Department of Obstetrics and Gynecology, University Hospital of Ioannina, Ioannina, Greece (Mitrogiannis, Katrachouras, Efthymiou, and G Makrydimas).
Second Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, Thessaloniki, Greece (Chatzakis and Sotiriadis).
Am J Obstet Gynecol MFM. 2024 Nov;6(11):101492. doi: 10.1016/j.ajogmf.2024.101492. Epub 2024 Sep 12.
This study aimed to assess the effect of elective fetal reduction on maternal-fetal outcomes in uncomplicated twin pregnancies compared with ongoing twin pregnancies.
The data sources included PubMed, Scopus (until December 2023), and references of retrieved articles.
We included clinical studies examining the association between selective fetal reduction of uncomplicated dichorionic twins on pregnancy outcomes.
Quality assessment of observational studies was conducted using the ROBINS-I tool. The overall quality of evidence was evaluated using the GRADE (Grading of Recommendations Assessment, Development and Evaluation) framework. A quantitative analysis was performed for electively reduced dichorionic twins. The primary outcome was preterm birth. The secondary outcomes were gestational age at delivery, stillbirth, neonatal intensive care unit admission, gestational diabetes mellitus, preeclampsia, and pregnancy loss at <24 weeks of gestation. Summary odds ratios with 95% confidence intervals were calculated, and random-effects models were used for data synthesis.
The initial electronic search yielded 745 studies; 175 studies were further identified from reference citations. Five articles included appropriate data and were finally included in the meta-analysis. All studies were evaluated as having "moderate risk of bias." These 5 studies reported on dichorionic twins. Elective reduction in dichorionic twins reduces the risk for preterm birth at <37 weeks (4 studies; n=1577; odds ratio, 0.14; 95% confidence interval, 0.09-0.22; moderate-quality evidence), <34 weeks (3 studies; n=1335; odds ratio, 0.22; 95% confidence interval, 0.07-0.69; low-quality evidence), and <32 weeks (3 studies; n=1335; odds ratio, 0.31; 95% confidence interval, 0.11-0.88; low-quality evidence), gestational diabetes (3 studies; n=1410; odds ratio, 0.57; 95% confidence interval, 0.33-0.97; low-quality evidence), pregnancy-associated hypertensive disorders (2 studies; n=581; odds ratio, 0.29; 95% confidence interval, 0.10-0.83; low-quality evidence), and birthweight <10th centile (2 studies; n=1163; odds ratio, 0.27; 95% confidence interval, 0.17-0.43; moderate-quality evidence) and <5th centile (2 studies; n=1163; odds ratio, 0.31; 95% confidence interval, 0.19-0.50; low-quality evidence), and increases gestational age at delivery (4 studies; n=1362; mean difference, 2.93 weeks; 95% confidence interval, 2.08-3.77; moderate-quality evidence). The risks for stillbirth (2 studies; n=1311; odds ratio, 1.63; 95% confidence interval, 0.43-6.21; very low-quality evidence) and pregnancy loss at <24 weeks (3 studies; n=1436; odds ratio, 1.20; 95% confidence interval, 0.55-2.58; very low-quality evidence) were not statistically significantly different.
Compared with ongoing dichorionic twin pregnancies, dichorionic pregnancies that undergo elective selective fetal reduction are associated with lower incidences of preterm birth at <37, <34, and <32 weeks, birthweight <10th and <5th centile, gestational diabetes, and hypertensive disorders of pregnancy, and later gestational age at delivery by almost 3 weeks. These associations were often based on very low-quality evidence. Thus, these results should be interpreted with caution, and further studies should be conducted. El resumen está disponible en Español al final del artículo.
本研究旨在评估与继续双胎妊娠相比,选择性胎儿减胎术对复杂双胎妊娠母婴结局的影响。
资料来源包括 PubMed、Scopus(截至 2023 年 12 月)和检索到的文章参考文献。
我们纳入了研究复杂双绒毛膜双胞胎选择性胎儿减胎术与妊娠结局之间关联的临床研究。
使用 ROBINS-I 工具对观察性研究进行质量评估。使用 GRADE(推荐评估、制定与评价)框架评估证据的总体质量。对选择性双绒毛膜双胞胎进行定量分析。主要结局是早产。次要结局包括分娩时的孕龄、死胎、新生儿重症监护病房入院、妊娠期糖尿病、子痫前期和妊娠 24 周前流产。计算汇总优势比和 95%置信区间,并使用随机效应模型进行数据分析。
最初的电子搜索产生了 745 项研究;从参考文献中进一步确定了 175 项研究。最终纳入了 5 项符合条件的数据的文章进行荟萃分析。所有研究均被评估为“中度偏倚风险”。这 5 项研究报告了双绒毛膜双胞胎的情况。选择性减少双绒毛膜双胞胎的妊娠可降低<37 周(4 项研究;n=1577;比值比,0.14;95%置信区间,0.09-0.22;中等质量证据)、<34 周(3 项研究;n=1335;比值比,0.22;95%置信区间,0.07-0.69;低质量证据)和<32 周(3 项研究;n=1335;比值比,0.31;95%置信区间,0.11-0.88;低质量证据)早产的风险,以及妊娠期糖尿病(3 项研究;n=1410;比值比,0.57;95%置信区间,0.33-0.97;低质量证据)、妊娠相关高血压疾病(2 项研究;n=581;比值比,0.29;95%置信区间,0.10-0.83;低质量证据)和出生体重<第 10 百分位数(2 项研究;n=1163;比值比,0.27;95%置信区间,0.17-0.43;中等质量证据)和<第 5 百分位数(2 项研究;n=1163;比值比,0.31;95%置信区间,0.19-0.50;低质量证据),并增加分娩时的孕龄(4 项研究;n=1362;平均差异,2.93 周;95%置信区间,2.08-3.77;中等质量证据)。死胎(2 项研究;n=1311;比值比,1.63;95%置信区间,0.43-6.21;极低质量证据)和妊娠 24 周前流产(3 项研究;n=1436;比值比,1.20;95%置信区间,0.55-2.58;极低质量证据)的风险没有统计学意义上的差异。
与继续双绒毛膜双胞胎妊娠相比,选择性选择性胎儿减胎的双绒毛膜双胞胎妊娠与<37 周、<34 周和<32 周早产、出生体重<第 10 百分位数和<第 5 百分位数、妊娠期糖尿病和妊娠相关高血压疾病以及孕龄晚近 3 周有关。这些关联通常基于极低质量的证据。因此,这些结果应谨慎解释,需要进一步研究。